#Fibrosis

Stanford geneticist Gary Peltz uses Co-Scientist to identify drug-repurposing candidates that could lead to new treatments for chronic liver disease and fibrosis

Label-free imaging technique can distinguish diseased cardiac tissue from healthy tissue and identify different types of fibrosis